VIEMED HEALTHCARE, INC. - Common Stock, no par value (VMD)

Historical Holders from Q1 2018 to Q4 2025

Type / Class
Equity / Common Stock, no par value
Symbol
VMD on Nasdaq
Shares outstanding
38,006,556
Price per share
$7.43
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
24,469,391
Total reported value
$166,145,413
% of total 13F portfolios
0%
Share change
-963,141
Value change
-$6,733,233
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
128
Price from insider filings
$7.31
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of VIEMED HEALTHCARE, INC. - Common Stock, no par value (VMD) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Forager Capital Management, LLC 7.2% +28% $18,580,645 +$3,734,500 2,736,472 +25% Forager Capital Management, LLC 30 Sep 2025
THRIVENT FINANCIAL FOR LUTHERANS 6.8% -22% $18,799,750 -$5,008,816 2,705,000 -21% THRIVENT FINANCIAL FOR LUTHERANS 31 Mar 2025
BlackRock Portfolio Management LLC 6.4% $17,564,888 2,540,114 BlackRock Portfolio Management LLC 30 Jun 2025
BlackRock, Inc. 5.8% $15,836,715 2,278,664 BlackRock, Inc. 31 Mar 2025
Nantahala Capital Management, LLC 2.9% $7,889,098 1,135,122 Nantahala Capital Management, LLC 30 Sep 2024
As of 30 Sep 2025, VIEMED HEALTHCARE, INC. - Common Stock, no par value (VMD) has 128 institutional shareholders filing 13F forms. They hold 24,469,391 shares. of 38,006,556 outstanding shares (64%) .

Top 25 institutional shareholders own 52% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
BlackRock, Inc. 13% 4,768,328 -1.1% 0% $32,376,946
Forager Capital Management, LLC 7.2% 2,736,472 +28% 8.2% $18,580,645
VANGUARD GROUP INC 4.7% 1,804,415 -0.86% 0% $12,251,978
GOLDMAN SACHS GROUP INC 3.7% 1,397,071 +84% 0% $9,486,112
Nantahala Capital Management, LLC 2.5% 932,445 0% 0.39% $6,331,302
GEODE CAPITAL MANAGEMENT, LLC 2.1% 797,647 -0.11% 0% $5,417,214
Kent Lake PR LLC 1.8% 700,000 -41% 2.4% $4,753,000
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. 1.8% 671,360 +9.5% 0.26% $4,558,534
STATE STREET CORP 1.7% 663,805 +0.65% 0% $4,507,236
First Eagle Investment Management, LLC 1.3% 477,844 +4.9% 0.01% $3,244,561
TOCQUEVILLE ASSET MANAGEMENT L.P. 1.2% 447,100 +7.2% 0.04% $3,035,809
RENAISSANCE TECHNOLOGIES LLC 1.2% 447,000 +8.9% 0% $3,035,130
PANAGORA ASSET MANAGEMENT INC 1.1% 433,929 +24% 0.01% $2,946,378
RAFFLES ASSOCIATES LP 1.1% 417,691 +3.7% 2.6% $2,836,122
Thrivent Financial for Lutherans 1% 384,000 -76% 0.01% $2,607,000
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 0.93% 352,323 +51% 0% $2,392,273
BARD ASSOCIATES INC 0.9% 340,997 +1.4% 0.61% $2,315,370
Qube Research & Technologies Ltd 0.77% 291,900 +37% 0% $1,982,001
SEGALL BRYANT & HAMILL, LLC 0.76% 289,446 0.03% $1,965,338
Penbrook Management LLC 0.72% 272,328 +51% 1.3% $1,849,107
NORTHERN TRUST CORP 0.71% 271,070 +0.46% 0% $1,840,565
MORGAN STANLEY 0.7% 265,565 -6.9% 0% $1,803,187
TWO SIGMA INVESTMENTS, LP 0.66% 251,410 +194% 0% $1,707,074
DIMENSIONAL FUND ADVISORS LP 0.59% 225,117 -18% 0% $1,528,103
Cove Street Capital, LLC 0.58% 219,848 +57% 1.9% $1,492,768

Institutional Holders of VIEMED HEALTHCARE, INC. - Common Stock, no par value (VMD) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q4 372,796 $2,769,460 +$200,247 742.82% 6
2025 Q3 24,469,391 $166,145,413 -$6,733,233 679% 128
2025 Q2 25,382,819 $175,380,483 +$3,214,401 691% 125
2025 Q1 24,854,089 $180,942,599 -$968,405 728% 138
2024 Q4 25,152,662 $201,731,507 +$494,659 802% 140
2024 Q3 25,209,952 $185,528,558 -$2,880,423 733% 120
2024 Q2 25,424,128 $166,525,006 +$2,341,353 655% 115
2024 Q1 24,742,775 $233,359,136 +$15,812,660 943% 110
2023 Q4 23,153,799 $181,860,450 -$2,819,118 785% 103
2023 Q3 23,498,774 $158,315,326 +$658,317 673% 108
2023 Q2 21,612,357 $211,412,065 +$18,552,064 978% 99
2023 Q1 22,327,255 $216,804,458 +$19,491,734 966% 88
2022 Q4 20,400,640 $151,789,368 +$14,144,812 756% 79
2022 Q3 18,250,089 $109,567,041 -$5,537,971 600.2% 62
2022 Q2 19,271,875 $103,931,514 -$6,869,539 538.03% 69
2022 Q1 21,895,744 $109,358,669 -$2,664,869 497.99% 83
2021 Q4 22,275,292 $116,280,510 -$3,324,259 522% 84
2021 Q3 21,412,001 $118,856,841 -$5,047,946 555.01% 76
2021 Q2 22,213,628 $158,888,686 +$5,893,070 715.07% 73
2021 Q1 21,098,814 $213,773,493 +$38,563,847 1,012.13% 97
2020 Q4 17,403,868 $135,434,917 +$1,660,932 776.04% 94
2020 Q3 17,235,387 $149,253,592 -$8,820,773 864.03% 96
2020 Q2 18,166,927 $174,463,830 +$57,819,391 959.75% 92
2020 Q1 12,364,664 $58,267,517 -$4,810,753 472.3% 41
2019 Q4 12,753,302 $79,748,952 +$2,084,226 624.98% 40
2019 Q3 12,248,232 $84,712,531 +$84,712,531 690.45% 35
2018 Q4 0 $0 -$218,000 0
2018 Q3 42,000 $218,000 -$18,167 519.05% 1
2018 Q2 45,500 $160,000 351.65% 1
2018 Q1 45,500 $111,000 +$111,000 243.96% 1